2019-nCoV Vaccine mRNA-1273 [vakcína firmy Moderna proti COVID-19]
topical
5
- Terms
-
2019-nCoV vakcína mRNA-1273
CX-024414
elasomeran
M-1273
mRNA-1273
mRNA-1273.211
Spikevax
TAK-919
vakcína Moderna proti covidu-19
vakcína proti COVID-19, Moderna
vakcína proti covidu-19, Moderna
vakcína Spikevax
-
COVID-19 Vaccine Moderna
CX-024414
Elasomeran
M-1273
Moderna COVID-19 Vaccine
Moderna COVID-19 Vaccine RNA
Moderna COVID-19 Vaccine, Bivalent
mRNA-1273
mRNA-1273.211
Spikevax
TAK-919
Persistent link
https://www.medvik.cz/link/D000090983
Definition
mRNA vaccine against SARS-CoV-2, developed by Moderna.
- DUI
- D000090983 MeSH Browser
- CUI
- M000747630
- History note
- 2022(2021)
- Public note
- 2022; 2019-NCOV VACCINE MRNA-1273 was indexed under COVID-19 VACCINES 2021
Allowable subheadings
- AD
- administration & dosage 2
- AE
- adverse effects 2
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D12.776.828.868.228
Nucleic Acid-Based Vaccines
D12.776.828.868.228.500.875
BNT162b5
D20.215.894.865.450
Nucleic Acid-Based Vaccines
D20.215.894.865.450.500.875
BNT162b5
D20.215.894.899.085.750
BNT162b5
D23.050.865.450
Nucleic Acid-Based Vaccines
D23.050.865.450.500.875
BNT162b5